查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1771297

生物製程自动化市场：产业趋势及全球预测 - 依控制器类型、业务规模、操作模式、与生物处理系统的兼容性、主要地区

Bioprocess Automation Market: Industry Trends and Global Forecasts - Distribution by Type of Controller, Scale of Operation, Mode of Operation, Compatibility with Bioprocessing Systems, and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 237 Pages | 商品交期: 最快1-2个工作天内

价格

全球生物过程自动化市场：概览

全球生物製程自动化市场规模目前约 38亿美元。预计市场在预测期内的年复合成长率为 12%。

市场规模与机会分析依下列参数细分：

控制器类型

  • 上游/下游控制器系统
  • 生物过程控制软体

企业规模

  • 临床前/临床运营
  • 商业运营

操作模式

  • 批量/补料分批生产
  • 灌注生产

与生物製程系统相容

  • 一次性系统
  • 不銹钢/其他系统

主要地区

  • 北美
  • 欧洲
  • 亚太地区及其他地区世界

全球生物过程自动化市场：成长与趋势

近几十年来，生物製药因其疗效显着、安全性高以及能够治疗多种复杂疾病而日益受到青睐。生物製药治疗的成功促使众多利害关係人对生物製造中使用的传统设备进行现代化改造。值得注意的是，生物製程控制器和自动化系统克服了传统生物反应器系统的不足，成为生物製药产业的製程最佳化解决方案。此外，这些控制器和自动化系统利用製程分析技术工具，可无缝整合到生物製程设备中，提高可扩展性。

生物过程自动化市场-IMG1

此外，新冠疫情期间生物製剂需求的增加，也导致上述系统的采用率激增。因此，一些生物製程设备开发商增加了受控自动化系统的产品线，目的是提高生产力、缩短生产时间、降低产品成本并增强生物製程的灵活性。

全球生物过程自动化市场：关键洞察

本报告深入探讨了全球生物过程自动化市场的现状，并识别了该行业的潜在成长机会。报告的主要调查结果包括：

  • 全球不同地区的多家公司提供/开发超过120种生物製程控制器和自动化系统。
  • 超过40%的生物製程控制器和自动化系统用于下游製程最佳化，其次是近30%的控制器用于上游製程最佳化。
生物过程自动化市场-IMG2
  • 该领域的特点是近40%的小型企业占据主导地位，其中超过30%的企业开发用于上游製程的控制器。此外，超过50%的生物製程控制器和自动化系统供应商位于欧洲。
  • 目前的市场格局较为分散，既有老牌企业，也有新进者。
  • 成立于1970年之前的生物製程控制器和自动化系统供应商（依字母排列）主要包括Cytiva、Eppendorf、Merck、Parker Hannifin、Sartorius Stedim Biotech和Thermo Fisher Scientific。
  • 总部位于欧洲的开发商中，超过40%是中小企业，其中近75%位于德国、法国和瑞士。
  • 超过65%的生物製程控制器和自动化系统由知名/老牌企业提供，其中57%的参与者声称同时提供细胞培养和微生物发酵系统。
  • 为了获得竞争优势，生物製程控制器开发商目前正致力于将高阶功能整合到各自的产品中。
  • 工业界和非工业界已提交/授予近3,500项与生物製程控制器和自动化技术相关的专利，显示该领域的创新步伐加快。
  • 有相当一部分的专利是在北美提交/授予（约65%），主要专利权人包括GE Healthcare/Cytiva、Cytori Therapeutics、Xyleco、Inscripta、Lonza和Terumo BCT。
  • 为了满足日益成长的生物製程自动化需求，许多利害关係人着手实施技术先进的系统。
  • 鑑于生物製程控制器和自动化系统在减少人为错误和降低製程成本方面的潜力，其应用可能会增加；预计相关市场在预测期内的年复合成长率将达到12%。
生物过程自动化市场-IMG3

全球生物过程自动化市场：关键细分市场

依业务规模，市场分为临床前/临床及商业领域。目前，临床前/临床营运领域在全球生物过程自动化市场中占有最大占有率（约75%）。预计未来这一趋势将保持不变。

依控制器类型，市场分为上下游控制器系统和生物製程控制软体。目前，上下游控制器系统领域在生物製程自动化市场中占有最大占有率（约60%）。

欧洲占最大市场占有率

根据主要地区，市场细分为北美、欧洲、亚太地区和世界其他地区。目前，欧洲（超过 40%）在生物过程自动化市场占据主导地位，占据最大的收入占有率。

生物过程自动化市场参与者

  • Applikon Biotechnology
  • Cytiva
  • Repligen
  • Sartorius
  • Sepragen
  • Solaris Biotech
  • Sysbiotech
  • Thermo Fisher Scientific

本报告调查全球生物製程自动化市场，提供市场概述，以及依控制器类型、企业规模、操作模式、与生物处理系统的兼容性、依地区划分的趋势以及参与市场的公司简介。

目录

第1章 前言

第2章 执行摘要

第3章 简介

  • 章节概述
  • 生物过程控制
  • 过程控制的组成部分
  • 製程控制的目标
  • 生物过程自动化
  • 生物过程自动化的优势
  • 自动化控制的挑战
  • 生物过程控制的突破
  • 未来展望

第4章 市场格局：上游控制器

  • 章节概述
  • 上游控制器：产品线
  • 上游控制器：开发者格局

第5章 市场市场格局：下游控制器系统

  • 章节概述
  • 下游控制器系统：产品线
  • 下游控制器系统：开发商格局

第6章 市场格局：生物製程控制软体

  • 章节概述
  • 生物製程控制软体：产品线
  • 生物製程控制软体：开发商格局

第7章 产品竞争力分析

  • 章节概述
  • 研究方法
  • 假设/关键参数
  • 产品竞争力分析：上游控制器
  • 产品竞争力分析：下游控制器系统
  • 产品竞争力分析：生物製程控制器软体

第8章 北美生物製程控制器与自动化系统开发商：公司简介

  • 章节概述
  • Cytiva Lifesciences
  • Thermo Fisher Scientific
  • Sepragen
  • Repligen

第9章 欧洲生物过程控制器与自动化系统开发商：公司简介

  • 章节概述
  • Applikon Biotechnology
  • Sartorius
  • Solaris Biotech
  • Sysbiotech

第10章 市场趋势分析

  • 章节概述
  • 世界地图图示：依总部位置和产品类型分析参与者
  • 市场趋势分析：上游控制器
  • 市场趋势分析：下游控制器系统
  • 市场趋势分析：生物製程控制软体

第11章 专利分析

  • 章节概述
  • 研究范围与方法
  • 生物製程控制器与自动化系统：专利分析
  • 专利基准分析
  • 生物製程控制器与自动化系统：专利估值分析
  • 引用次数最高的专利

第12章 品牌定位分析

  • 章节概述
  • 研究方法
  • 关键参数
  • 上游控制器开发商的品牌定位矩阵
  • 下游控制系统开发商的品牌定位矩阵
  • 生物製程控制器软体开发商的品牌定位矩阵

第13章 市场预测与机会分析

  • 章节概述
  • 预测研究方法与关键假设
  • 2035年生物製程控制器与自动化市场整体规模
  • 2035年生物製程控制器与自动化市场（依控制器类型）
  • 2035年生物製程控制器与自动化市场（依企业规模）
  • 2035年生物製程控制器与自动化市场（依操作模式）
  • 2035年生物製程控制器与自动化市场（依系统类型）
  • 2035年生物製程控制器与自动化市场（依主要区域）

第14章 结论

第15章 高层洞察

第16章 附录1：表格资料

第17章 附录2：公司与组织清单

Product Code: RA100298

GLOBAL BIOPROCESS AUTOMATION MARKET: OVERVIEW

As per Roots Analysis, the bioprocess automation market valued at USD 3.8 billion in the current year is anticipated to grow at a CAGR of 12% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Controller

  • Upstream / Downstream Controller System
  • Bioprocess Control Software

Scale of Operation

  • Preclinical / Clinical Operation
  • Commercial Operation

Mode of Operation

  • Batch / Fed-Batch Manufacturing
  • Perfusion Manufacturing

Compatibility with Bioprocessing Systems

  • Single-Use Systems
  • Stainless Steel / Other Systems

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific and Rest of the World

GLOBAL BIOPROCESS AUTOMATION MARKET: GROWTH AND TRENDS

In recent decades, biopharmaceuticals have become increasingly popular due to their therapeutic effectiveness, favorable safety profiles, and capacity to address a wide range of complex diseases. The success of treatments with the use of biopharmaceuticals has encouraged several stakeholders to modernize traditional equipment used for biological manufacturing. Notably, the bioprocess controllers and automation systems have turned out to be a process optimization solution for the biopharmaceutical industries, overcoming the inadequacy of the traditional bioreactor systems. Moreover, these controllers and automated systems utilize process analytical technology tools that can be seamlessly integrated into bioprocessing units to enhance scalability.

Bioprocess Automation Market - IMG1

Further, amidst the COVID-19 pandemic, the increasing demand for biologics has led to the surge in the adoption rate of the aforementioned systems. As a result, several bioprocess equipment developers increased their controlled and automated systems offerings in order to increase productivity, shorten production timelines, reduce cost of goods, and increase flexibility of the bioprocess.

GLOBAL BIOPROCESS AUTOMATION MARKET: KEY INSIGHTS

The report delves into the current state of global bioprocess automation market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Over 120 bioprocess controllers and automation systems are available / being developed by various companies based in different regions across the globe; majority of the controllers are designed for upstream processes.
  • Over 40% of the bioprocess controllers and automation systems are being offered to optimize the downstream processes, followed by nearly 30% controllers, which are used to optimize upstream processes.
Bioprocess Automation Market - IMG2
  • The domain is featured by the presence of nearly 40% small players; of which, over 30% of players are developing upstream controllers. Further, more than 50% of these players offering bioprocess controllers and automation systems are based in Europe.
  • The current market landscape is fragmented, featuring the presence of both established players and new entrants; most of the companies are headquartered in developed nations.
  • Prominent examples of bioprocess controllers and automated system providers established before 1970 (in alphabetical order) include Cytiva, Eppendorf, Merck, Parker Hannifin, Sartorius Stedim Biotech and Thermo Fisher Scientific.
  • More than 40% developers headquartered in Europe are small and mid-sized players; of these, close to 75% companies are located in Germany, France, and Switzerland.
  • Over 65% of bioprocess controllers and automation systems are offered by known / established players; of these, 57% of the stakeholders claim to offer systems for both cell cultivation and microbial fermentation.
  • In pursuit of gaining a competitive edge, bioprocess controller developers are presently focusing on the integration of advanced features into their respective products.
  • Close to 3,500 patents related to bioprocess controller and automation technologies have been filed / granted to industry and non-industry players, indicating the enhanced pace of innovation in this field.
  • A significant proportion of patents have been filed / granted in North America (~65%); key patent assignees include GE Healthcare / Cytiva, Cytori Therapeutics, Xyleco, Inscripta, Lonza, and Terumo BCT.
  • Over time, several stakeholders have established strong brand positions; in order to cater to increasing demand for bioprocess automation, a number of players have stepped up to introduce technologically advanced systems.
  • Given the potential to reduce human errors and process costs, the adoption of bioprocess controllers and automation systems is likely to increase; the affiliated market is expected to grow at a CAGR of 12% during the forecast period.
Bioprocess Automation Market - IMG3

GLOBAL BIOPROCESS AUTOMATION MARKET: KEY SEGMENTS

Preclinical / Clinical Segment Occupies the Largest Share of the Bioprocess Automation Market

Based on the scale of operation, the market is segmented into preclinical / clinical operations and commercial operations. At present, preclinical / clinical operations segment holds the maximum (~75%) share of the global bioprocess automation market. This trend is likely to remain same in the coming future.

By Type of Controller, Upstream / Downstream Controller System Segment Accounts for the Largest Share in the Bioprocess Automation Market

Based on the type of controller, the market is segmented into upstream / downstream controller system and bioprocess control software. Currently, upstream / downstream controller system segment captures the highest proportion (~60%) of the bioprocess automation market.

Europe Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, and Asia-Pacific and Rest of the World. Currently, Europe (>40%) dominates the bioprocess automation market and accounts for the largest revenue share.

Example Players in the Bioprocess Automation Market

  • Applikon Biotechnology
  • Cytiva
  • Repligen
  • Sartorius
  • Sepragen
  • Solaris Biotech
  • Sysbiotech
  • Thermo Fisher Scientific

GLOBAL BIOPROCESS AUTOMATION MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global bioprocess automation market, focusing on key market segments, including [A] type of controller, [B] scale of operation, [C] mode of operation, [D] compatibility with bioprocessing systems and [E] key geographical regions.
  • Market Landscape: A comprehensive evaluation of bioprocess controllers and automation systems, considering various parameters, such as [A] scale of operation, [B] mode of operation, [C] key features, [D] compatibility with the bioprocessing systems, [E] type of system(s) and [F] type of processes controlled. Additionally, a comprehensive analysis of the companies developing bioprocess controllers and automation systems, based on [A] year of establishment, [B] company size, and [C] geographical presence.
  • Product Competitiveness Analysis: A comprehensive competitive analysis of upstream controllers, downstream controller systems and process control software, examining factors, such as [A] product applicability and [B] product strength.
  • Company Profiles: In-depth profiles companies providing upstream controllers, downstream controller systems and process control software, focusing on [A] company overview, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
  • Key Insights: In-depth analysis of market trends, focusing on [A] regional distribution of players and [B] type of products offered. Additionally, a [C] distribution of upstream controllers, based on compatibility with bioreactor systems, scale of operation and mode of operation, [D] an analysis of upstream controllers, based on scale of operation, compatibility with bioreactor systems and processes controlled [E] an analysis of downstream controller systems, based on scale of operation, type of systems and key features, [F] an analysis of downstream controller systems, based on mode of operation and application area [G] an analysis of bioprocess control software, based on scale of operation, key features and processes controlled and [H] an analysis of bioprocess control software, based on scale of operation and compatibility with bioprocessing systems.
  • Patent Analysis: An insightful analysis of various patents that have been filed / granted for bioprocess controllers and automation systems, based on several parameters, such as [A] type of patents, [B] publication year, [C] application year, [D] issuing authorities involved, [E] type of organizations, [F] emerging focus area, [G] patent age, [H] CPC symbols, [I] leading patent assignees (in terms of number of patents granted / filed), [J] patent characteristics, [K] geography, [L] patent benchmarking and [M] an insightful valuation analysis.
  • Brand Positioning Analysis: In-depth analysis of brand positioning of the key industry players, highlighting the current perceptions regarding their proprietary products based on several relevant factors, such as [A] experience of the manufacturer, [B] number of products offered, [C] product diversity and [D] number of patents published.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Bioprocess Control
  • 3.3. Building Block of Process Control
    • 3.3.1. Components of Process Control Systems
      • 3.3.1.1. Sensors
      • 3.3.1.2. Actuators
      • 3.3.1.3. Controllers
  • 3.4. Purpose of Process Control
  • 3.5. Bioprocess Automation
  • 3.6. Advantages of Bioprocess Automation
  • 3.7. Challenges Faced in Automated Control
    • 3.7.1. Process Related Challenges to Automate
    • 3.7.2. Compatibility and Infrastructure Challenges
    • 3.7.3. Regulatory Challenges
    • 3.7.4. IT Concerns and Data Integrity
  • 3.8. Breakthrough in Bioprocess Control
    • 3.8.1. Flexible and Automated Skids
    • 3.8.2. Spectroscopy
    • 3.8.3. Multivariate data Analytics
  • 3.9. Future Perspective

4. MARKET LANDSCAPE: UPSTREAM CONTROLLERS

  • 4.1. Chapter Overview
  • 4.2. Upstream Controllers: Product Pipeline
    • 4.2.1. Analysis by Scale of Operation
    • 4.2.2. Analysis by Key Features
    • 4.2.3. Analysis by Compatibility with Bioreactor System
    • 4.2.4. Analysis by Mode of Operation
    • 4.2.5. Analysis by Types of Processes Controlled
  • 4.3. Upstream Controllers: Developer Landscape
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters
    • 4.3.4. Leading Developers: Analysis by Number of Upstream Controllers

5. MARKET LANDSCAPE: DOWNSTREAM CONTROLLER SYSTEMS

  • 5.1. Chapter Overview
  • 5.2. Downstream Controller Systems: Product Pipeline
    • 5.2.1. Analysis by Scale of Operation
    • 5.2.2. Analysis by Key Features
    • 5.2.3. Analysis by Types of Systems Involved
    • 5.2.4. Analysis by Mode of Operation
    • 5.2.5. Analysis by Application Area
  • 5.3. Downstream Controller Systems: Developer Landscape
    • 5.3.1. Analysis by Year of Establishment
    • 5.3.2. Analysis by Company Size
    • 5.3.3. Analysis by Location of Headquarters
    • 5.3.4. Leading Developers: Analysis by Number of Products

6. MARKET LANDSCAPE: BIOPROCESS CONTROL SOFTWARE

  • 6.1. Chapter Overview
  • 6.2. Bioprocess Control Software: Product Pipeline
    • 6.2.1. Analysis by Stage of Bioprocess
    • 6.2.2. Analysis by Scale of Operation
    • 6.2.3. Analysis by Key Features
    • 6.2.4. Analysis by Compatibility with Systems
    • 6.2.5. Analysis by Types of Processes Controlled
  • 6.3. Bioprocess Control Software: Developer Landscape
    • 6.3.1. Analysis by Year of Establishment
    • 6.3.2. Analysis of Company Size
    • 6.3.3. Analysis by Location of Headquarters
    • 6.3.4. Leading Developers: Analysis by Number of Bioprocess Control Software

7. PRODUCT COMPETITIVENESS ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Methodology
  • 7.3. Assumptions / Key Parameters
  • 7.4. Product Competitiveness Analysis: Upstream Controllers
  • 7.5. Product Competitiveness Analysis: Downstream Controller Systems
  • 7.6. Product Competitiveness Analysis: Bioprocess Controller Software

8. BIOPROCESS CONTROLLER AND AUTOMATION SYSTEM DEVELOPERS IN NORTH AMERICA: COMPANY PROFILES

  • 8.1. Chapter Overview
  • 8.2. Cytiva Lifesciences
    • 8.2.1. Company Overview
    • 8.2.2. Bioprocess Controller and Automation System Portfolio
    • 8.2.3. Recent Developments and Future Outlook
  • 8.3. Thermo Fisher Scientific
    • 8.3.1. Company Overview
    • 8.3.2. Bioprocess Controller and Automation System Portfolio
    • 8.3.3. Recent Developments and Future Outlook
  • 8.4. Sepragen
    • 8.4.1. Company Overview
    • 8.4.2. Bioprocess Controller and Automation System Portfolio
    • 8.4.3. Recent Developments and Future Outlook
  • 8.5. Repligen
    • 8.5.1. Company Overview
    • 8.5.2. Bioprocess Controller and Automation System Portfolio
    • 8.5.3. Recent Developments and Future Outlook

9. BIOPROCESS CONTROLLER AND AUTOMATION SYSTEM DEVELOPERS IN EUROPE: COMPANY PROFILES

  • 9.1. Chapter Overview
  • 9.2. Applikon Biotechnology
    • 9.2.1. Company Overview
    • 9.2.2. Bioprocess Controller and Automation System Portfolio
    • 9.2.3. Recent Developments and Future Outlook
  • 9.3. Sartorius
    • 9.3.1. Company Overview
    • 9.3.2. Bioprocess Controller and Automation System Portfolio
    • 9.3.3. Recent Developments and Future Outlook
  • 9.4. Solaris Biotech
    • 9.4.1. Company Overview
    • 9.4.2. Bioprocess Controller and Automation System Portfolio
    • 9.4.3. Recent Developments and Future Outlook
  • 9.5. Sysbiotech
    • 9.5.1. Company Overview
    • 9.5.2. Bioprocess Controller and Automation System Portfolio
    • 9.5.3. Recent Developments and Future Outlook

10. MARKET TREND ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. World Map Representation: Analysis of Players by Location of Headquarters and Type of Product(s) Offered
  • 10.3. Market Trend Analysis: Upstream Controllers
    • 10.3.1. Heat Map Representation: Analysis by Scale of Operation, Compatibility with Bioreactor Systems and Operating Mode
    • 10.3.2. Grid Analysis: Analysis by Scale of Operation, Compatibility with Bioreactor Systems and Types of Processes Controlled
  • 10.4. Market Trend Analysis: Downstream Controller Systems
    • 10.4.1. Grid Analysis: Analysis by Scale of Operation, Type of System(s) and Key Features
    • 10.4.2. Analysis by Operation Mode and Application Area
  • 10.5. Market Trend Analysis: Bioprocess Control Software
    • 10.5.1. Grid Analysis: Analysis by Scale of Operation, Key Features and Types of Processes Controlled
    • 10.5.2. Analysis by Scale of operation and Compatibility with Systems

11. PATENT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Bioprocess Controller and Automations Systems: Patent Analysis
    • 11.3.1. Analysis by Publication Year
    • 11.3.2. Analysis by Application Year
    • 11.3.3. Analysis by Patent Office
    • 11.3.4. Analysis by Geographical Location
    • 11.3.5. Analysis by CPC Symbols
    • 11.3.6. Emerging Focus Area
    • 11.3.7. Analysis by Type of Organization
    • 11.3.8. Leading Players: Analysis by Number of Patents
  • 11.4. Patent Benchmarking Analysis
    • 11.4.1. Analysis by Patent Characteristics
  • 11.5. Bioprocess Controller and Automations Systems: Patent Valuation Analysis
  • 11.6. Leading Patents by Number of Citations

12. BRAND POSITIONING ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Methodology
  • 12.3. Key Parameters
  • 12.4. Brand Positioning Matrix of Upstream Controller Developers
    • 12.4.1. Brand Positioning Matrix: Applikon Biotechnology
    • 12.4.2. Brand Positioning Matrix: Eppendorf
    • 12.4.3. Brand Positioning Matrix: Thermo Fisher Scientific
    • 12.4.4. Brand Positioning Matrix: ILS Automation
    • 12.4.5. Brand Positioning Matrix: Pierre Guerin
  • 12.5. Brand Positioning Matrix of Downstream Controller System Developers
    • 12.5.1. Brand Positioning Matrix: Cytiva Lifesciences
    • 12.5.2. Brand Positioning Matrix: Sepragen
    • 12.5.3. Brand Positioning Matrix: Merck Millipore
    • 12.5.4. Brand Positioning Matrix: Sartorius Stedim Biotech
    • 12.5.5. Brand Positioning Matrix: Repligen
    • 12.5.6. Brand Positioning Matrix: Agilitech
  • 12.6. Brand Positioning Matrix of Bioprocess Controller Software Developers
    • 12.6.1. Brand Positioning Matrix: Applikon Biotechnology
    • 12.6.2. Brand Positioning Matrix: Pierre Guerin
    • 12.6.3. Brand Positioning Matrix: Thermo Fisher Scientific
    • 12.6.4. Brand Positioning Matrix: Merck Millipore
    • 12.6.5. Brand Positioning Matrix: Sartorius Stedim Biotech
    • 12.6.6. Brand Positioning Matrix: Cytiva Lifesciences
    • 12.6.7. Brand Positioning Matrix: Bionet Engineering

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 13.1. Chapter Overview
  • 13.2. Forecast Methodology and Key Assumptions
  • 13.3. Overall Bioprocess Controller and Automation Market, Till 2035
  • 13.4. Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Controller
    • 13.4.1. Bioprocess Controller and Automation Market for Upstream / Downstream Controller Systems, Till 2035
    • 13.4.2. Bioprocess Controller and Automation Market for Bioprocess Control Software, Till 2035
  • 13.5. Bioprocess Controller and Automation Market, Till 2035: Distribution by Scale of Operation
    • 13.5.1. Bioprocess Controller and Automation Market for Preclinical / Clinical Operations, Till 2035
    • 13.5.2. Bioprocess Controller and Automation Market for Commercial Operations, Till 2035
  • 13.6. Bioprocess Controller and Automation Market, Till 2035: Distribution by Mode of Operation
    • 13.6.1. Bioprocess Controller and Automation Market for Batch / Fed-batch Manufacturing, Till 2035
    • 13.6.2. Bioprocess Controller and Automation Market for Perfusion Manufacturing, Till 2035
  • 13.7. Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Systems
    • 13.7.1. Bioprocess Controller and Automation Market for Single-use Systems, Till 2035
    • 13.7.2. Bioprocess Controller and Automation Market for Stainless Steel / Other Systems, Till 2035
  • 13.8. Bioprocess Controller and Automation Market, Till 2035: Distribution by Key Geographical Regions
    • 13.8.1. Bioprocess Controller and Automation Market in North America, Till 2035
    • 13.8.2. Bioprocess Controller and Automation Market in Europe, Till 2035
    • 13.8.3. Bioprocess Controller and Automation Market in Asia-Pacific and Rest of the World, Till 2035

14. CONCLUSION

  • 14.1. Chapter Overview

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 4.1 Upstream Controllers: Information on Dimensions and Scale of Operation
  • Table 4.2 Upstream Controllers: Information on Key Features, Mode of Operation, Compatibility with Bioreactor Systems and Types of Processes Controlled
  • Table 4.3 Upstream Controller Developers: Information of Year of Establishment, Company Size and Location of Headquarters
  • Table 5.1 Downstream Controller Systems: Information on Dimensions, Type of Controllers and Scale of Operation
  • Table 5.2 Downstream Controller Systems: Information on Key Features, Type of Bioprocessing System(s) Involved, Mode of Operation and Application Area
  • Table 5.3 Downstream Controller System Developers: Information of Year of Establishment, Company Size and Location of Headquarters
  • Table 6.1 Bioprocess Control Software: Information on Stage of Bioprocess and Scale of Operation
  • Table 6.2 Bioprocess Control Software: Information on Key Features, Compatibility with Bioprocessing Systems and Types of Processes Controlled
  • Table 6.3 Bioprocess Control Software Developers: Information of Year of Establishment, Company Size and Location of Headquarters
  • Table 8.1 Bioprocess Controllers and Automation: List of Companies Profiled
  • Table 8.2 Cytiva Lifesciences: Company Snapshot
  • Table 8.3 Cytiva Lifesciences: Product Portfolio (Downstream Controller Systems)
  • Table 8.4 Cytiva Lifesciences: Product Portfolio (Bioprocess Control Software)
  • Table 8.5 Cytiva Lifesciences: Recent Developments and Future Outlook
  • Table 8.6 Thermo Fisher Scientific: Company Snapshot
  • Table 8.7 Thermo Fisher Scientific: Product Portfolio (Upstream Controllers)
  • Table 8.8 Thermo Fisher Scientific: Product Portfolio (Bioprocess Control Software)
  • Table 8.9 Thermo Fisher Scientific: Recent Developments and Future Outlook
  • Table 8.10 Sepragen: Company Snapshot
  • Table 8.11 Sepragen: Product Portfolio (Downstream Controller Systems)
  • Table 8.12 Repligen Corporation: Company Snapshot
  • Table 8.13 Repligen: Product Portfolio (Downstream Controller Systems)
  • Table 8.14 Repligen Corporation: Recent Developments and Future Outlook
  • Table 9.1 Bioprocess Controllers and Automation: List of Companies Profiled
  • Table 9.2 Applikon Biotechnology: Company Snapshot
  • Table 9.3 Applikon Biotechnology: Product Portfolio (Upstream Controllers)
  • Table 9.4 Applikon Biotechnology: Product Portfolio (Bioprocess Control Software)
  • Table 9.5 Applikon biotechnology: Recent Developments and Future Outlook
  • Table 9.6 Sartorius: Company Snapshot
  • Table 9.7 Sartorius: Product Portfolio (Upstream Controllers)
  • Table 9.8 Sartorius: Product Portfolio (Downstream Controller Systems)
  • Table 9.9 Sartorius: Product Portfolio (Bioprocess Control Software)
  • Table 9.10 Sartorius: Recent Developments and Future Outlook
  • Table 9.11 Solaris Biotech: Company Snapshot
  • Table 9.12 Solaris Biotech: Product Portfolio (Upstream Controllers)
  • Table 9.13 Solaris Biotech: Product Portfolio (Downstream Controller Systems)
  • Table 9.14 Solaris Biotech: Product Portfolio (Bioprocess Control Software)
  • Table 9.15 Solaris Biotech: Recent Developments and Future Outlook
  • Table 9.16 Sysbiotech: Company Snapshot
  • Table 9.17 Sysbiotech: Product Portfolio (Upstream Controllers)
  • Table 9.18 Sysbiotech: Recent Developments and Future Outlook
  • Table 11.1 Patent Analysis: Prominent CPC Symbols
  • Table 11.2 Patent Analysis: List of Top CPC Symbols
  • Table 11.3 Patent Analysis: Leading CPC Symbol Definitions
  • Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
  • Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
  • Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
  • Table 16.1 Upstream Controllers: Distribution by Scale of Operation
  • Table 16.2 Upstream Controllers: Distribution by Key Features
  • Table 16.3 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
  • Table 16.4 Upstream Controllers: Distribution by Mode of Operation
  • Table 16.5 Upstream Controllers: Distribution by Types of Processes Controlled
  • Table 16.6 Upstream Controller Developers: Distribution by Year of Establishment
  • Table 16.7 Upstream Controller Developers: Distribution by Company Size
  • Table 16.8 Upstream Controller Developers: Distribution by Location of Headquarters
  • Table 16.9 Leading Developers: Distribution by Number of Products
  • Table 16.10 Downstream Controller Systems: Distribution by Scale of Operation
  • Table 16.11 Downstream Controller Systems: Distribution by Key Features
  • Table 16.12 Downstream Controller Systems: Distribution by Type of Bioprocessing System(s)
  • Table 16.13 Downstream Controller Systems: Distribution by Mode of Operation
  • Table 16.14 Downstream Controller Systems: Distribution by Application Area
  • Table 16.15 Downstream Controller System Developers: Distribution by Year of Establishment
  • Table 16.16 Downstream Controller System Developers: Distribution by Company Size
  • Table 16.17 Downstream Controller System Developers: Distribution by Location of Headquarters
  • Table 16.18 Leading Developers: Distribution by Number of Products
  • Table 16.19 Bioprocess Control Software: Distribution by Stage of Bioprocess
  • Table 16.20 Bioprocess Control Software: Distribution by Scale of Operation
  • Table 16.21 Bioprocess Control Software: Distribution by Key Features
  • Table 16.22 Bioprocess Control Software: Distribution by Compatibility with Bioprocessing Systems
  • Table 16.23 Bioprocess Control Software: Distribution by Types of Processes Controlled
  • Table 16.24 Bioprocess Control Software Developers: Distribution by Year of Establishment
  • Table 16.25 Bioprocess Control Software Developers: Distribution by Company Size
  • Table 16.26 Bioprocess Control Software Developers: Distribution by Location of Headquarters
  • Table 16.27 Leading Developers: Distribution by Number of Products
  • Table 16.28 Downstream Controller System: Distribution by Operating Mode and Application Area
  • Table 16.29 Bioprocess Control Software: Distribution by Scale of Operation and Compatibility with Systems
  • Table 16.30 Patent Analysis: Distribution by Type of Patent
  • Table 16.31 Patent Analysis: Cumulative Distribution by Publication Year, Since Pre-2015
  • Table 16.32 Patent Analysis: Distribution by Application Year, Since Pre-2015
  • Table 16.33 Patent Analysis: Distribution by Patent Office
  • Table 16.34 Patent Analysis: Distribution by Geographical Location
  • Table 16.35 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization
  • Table 16.36 Patent Analysis: Leading Industry Players
  • Table 16.37 Patent Analysis: Leading Non-Industry Players
  • Table 16.38 Patent Analysis: Leading Individual Assignees
  • Table 16.39 Patent Analysis: Distribution of Patents by Age Since 2001
  • Table 16.40 Bioprocess Controllers and Automation Systems: Patent Valuation
  • Table 16.41 Overall Bioprocess Controllers and Automation Systems Market, Till 2035 (USD Million)
  • Table 16.42 Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Controller (USD Million)
  • Table 16.43 Bioprocess Controller and Automation Market for Upstream / Downstream Controller Systems, Till 2035 (USD Million)
  • Table 16.44 Bioprocess Controller and Automation Market for Bioprocess Control Software, Till 2035 (USD Million)
  • Table 16.45 Bioprocess Controller and Automation Market, Till 2035: Distribution by Scale of Operation (USD Million)
  • Table 16.46 Bioprocess Controller and Automation Market for Preclinical / Clinical Operations, Till 2035 (USD Million)
  • Table 16.47 Bioprocess Controller and Automation Market for Commercial Operations, Till 2035 (USD Million)
  • Table 16.48 Bioprocess Controller and Automation Market, Till 2035: Distribution by Mode of Operation (USD Million)
  • Table 16.49 Bioprocess Controller and Automation Market for Batch / Fed-batch Manufacturing, Till 2035 (USD Million)
  • Table 16.50 Bioprocess Controller and Automation Market for Perfusion Manufacturing, Till 2035 (USD Million)
  • Table 16.51 Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Bioprocessing Systems (USD Million)
  • Table 16.52 Bioprocess Controller and Automation Market for Single-use Systems, Till 2035 (USD Million)
  • Table 16.53 Bioprocess Controller and Automation Market for Stainless Steel / Other Systems, Till 2035 (USD Million)
  • Table 16.54 Bioprocess Controller and Automation Market, Till 2035: Distribution by Key Geographical Regions (USD Million)
  • Table 16.55 Bioprocess Controller and Automation Market in North America, Till 2035 (USD Million)
  • Table 16.56 Bioprocess Controller and Automation Market in Europe, Till 2035 (USD Million)
  • Table 16.57 Bioprocess Controller and Automation Market in Asia-Pacific and Rest of the World, Till 2035 (USD Million)

List of Figures

  • Figure 2.1 Executive Summary: Current Market Landscape of Upstream Controllers
  • Figure 2.2 Executive Summary: Current Market Landscape of Downstream Controller Systems
  • Figure 2.3 Executive Summary: Current Market Landscape of Bioprocess Control Software
  • Figure 2.4 Executive Summary: Patent Analysis
  • Figure 2.5 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 3.1 Factors Affecting Manufacturing Process of Biologics
  • Figure 3.2 Overview of Controlled Parameters in Bioreactors
  • Figure 3.3 Basic Bioprocess Control Model
  • Figure 3.4 Advantages of Bioprocess Automation
  • Figure 4.1 Upstream Controllers: Distribution by Scale of Operation
  • Figure 4.2 Upstream Controllers: Distribution by Key Features
  • Figure 4.3 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
  • Figure 4.4 Upstream Controllers: Distribution by Mode of Operation
  • Figure 4.5 Upstream Controllers: Distribution by Types of Processes Controlled
  • Figure 4.6 Upstream Controller Developers: Distribution by Year of Establishment
  • Figure 4.7 Upstream Controller Developers: Distribution by Company Size
  • Figure 4.8 Upstream Controller Developers: Distribution by Location of Headquarters
  • Figure 4.9 Leading Developers: Distribution by Number of Products
  • Figure 5.1 Downstream Controller Systems: Distribution by Scale of Operation
  • Figure 5.2 Downstream controller systems: Distribution by Key Features
  • Figure 5.3 Downstream Controller Systems: Distribution by Type of Bioprocessing System(s)
  • Figure 5.4 Downstream Controller Systems: Distribution by Mode of Operation
  • Figure 5.5 Downstream Controller Systems: Distribution by Application Area
  • Figure 5.6 Downstream Controller System Developers: Distribution by Year of Establishment
  • Figure 5.7 Downstream Controller System Developers: Distribution by Company Size
  • Figure 5.8 Downstream Controller System Developers: Distribution by Location of Headquarters
  • Figure 5.9 Leading Developers: Distribution by Number of Products
  • Figure 6.1 Bioprocess Control Software: Distribution by Stage of Bioprocess
  • Figure 6.2 Bioprocess Control Software: Distribution by Scale of Operation
  • Figure 6.3 Bioprocess Control Software: Distribution by Key Features
  • Figure 6.4 Bioprocess Control Software: Distribution by Compatibility with Bioprocessing Systems
  • Figure 6.5 Bioprocess Control Software: Distribution by Types of Processes Controlled
  • Figure 6.6 Bioprocess Control Software Developers: Distribution by Year of Establishment
  • Figure 6.7 Bioprocess Control Software Developers: Distribution by Company Size
  • Figure 6.8 Bioprocess Control Software Developers: Distribution by Location of Headquarters
  • Figure 6.9 Leading Developers: Distribution by Number of Products
  • Figure 7.1 Product Competitiveness Analysis: Upstream Controllers
  • Figure 7.2 Product Competitiveness Analysis: Downstream Controller Systems (Chromatography Systems)
  • Figure 7.3 Product Competitiveness Analysis: Downstream Controller Systems (Tangential Flow Filtration Systems Systems)
  • Figure 7.4 Product Competitiveness Analysis: Bioprocess Control Software
  • Figure 10.1 World Map Representation: Distribution by Location of Headquarters and Type of Product(s) Offered
  • Figure 10.2 Heat Map Representation: Distribution by Scale of Operation, Compatibility with Bioreactor Systems and Mode of Operation
  • Figure 10.3 Grid Analysis: Distribution by Upstream Controllers by Scale of Operation, Compatibility with Bioreactor Systems and Types of Processes Controlled
  • Figure 10.4 Grid Analysis: Distribution by Scale of Operation, Type of Bioprocessing System(s) and Key Features
  • Figure 10.5 Downstream Controller System: Distribution by Mode of Operation and Application Area
  • Figure 10.6 Grid Analysis: Distribution by Scale of Operation, Key Features and Types of Processes Controlled
  • Figure 10.7 Bioprocess Control Software: Distribution by Scale of Operation and Compatibility with Bioprocessing Systems
  • Figure 11.1 Patent Analysis: Distribution by Type of Patent
  • Figure 11.2 Patent Analysis: Cumulative Distribution by Publication Year, Since Pre-2015
  • Figure 11.3 Patent Analysis: Distribution by Application Year, Since Pre-2015
  • Figure 11.4 Patent Analysis: Distribution by Patent Office
  • Figure 11.5 Patent Analysis: Distribution by Geographical Location
  • Figure 11.6 Patent Analysis: Distribution by CPC Symbols
  • Figure 11.7 Patent Analysis: Emerging Focus Areas
  • Figure 11.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization
  • Figure 11.9 Patent Analysis: Leading Industry Players
  • Figure 11.10 Patent Analysis: Leading Non-Industry Players
  • Figure 11.11 Patent Analysis: Leading Individual Assignees
  • Figure 11.12 Patent Analysis (Leading Industry Players): Benchmarking by Patent Characteristics (CPC Symbols)
  • Figure 11.13 Patent Analysis: Distribution of Patents by Age Since 2001
  • Figure 11.14 Bioprocess Controllers and Automation Systems: Patent Valuation
  • Figure 12.1 Brand Positioning Analysis of Upstream Controller Developers: Competitive Advantage
  • Figure 12.2 Brand Positioning Analysis of Upstream Controller Developers: Reasons to Believe
  • Figure 12.3 Brand Positioning Matrix: Applikon Biotechnology
  • Figure 12.4 Brand Positioning Matrix: Eppendorf
  • Figure 12.5 Brand Positioning Matrix: Thermo Fisher Scientific
  • Figure 12.6 Brand Positioning Matrix: ILS Automation
  • Figure 12.7 Brand Positioning Matrix: Pierre Guerin
  • Figure 12.8 Brand Positioning Analysis of Downstream Controller System Developers: Competitive Advantage
  • Figure 12.9 Brand Positioning Analysis of Downstream Controller System Developers: Reasons to Believe
  • Figure 12.10 Brand Positioning Matrix: Cytiva
  • Figure 12.11 Brand Positioning Matrix: Sepragen
  • Figure 12.12 Brand Positioning Matrix: Merck Millipore
  • Figure 12.13 Brand Positioning Matrix: Sartorius Stedim Biotech
  • Figure 12.14 Brand Positioning Matrix: Repligen
  • Figure 12.15 Brand Positioning Matrix: Agilitech
  • Figure 12.16 Brand Positioning Analysis of Bioprocess Control Software Developers: Competitive Advantage
  • Figure 12.17 Brand Positioning Analysis of Bioprocess Control Software Developers: Reasons to Believe
  • Figure 12.18 Brand Positioning Matrix: Applikon Biotechnology
  • Figure 12.19 Brand Positioning Matrix: Pierre Guerin
  • Figure 12.20 Brand Positioning Matrix: Thermo Fisher Scientific
  • Figure 12.21 Brand Positioning Matrix: Merck Millipore
  • Figure 12.22 Brand Positioning Matrix: Sartorius Stedim Biotech
  • Figure 12.23 Brand Positioning Matrix: Cytiva
  • Figure 12.24 Brand Positioning Matrix: Bionet Engineering
  • Figure 13.1 Overall Bioprocess Controllers and Automation Systems Market, Till 2035 (USD Million)
  • Figure 13.2 Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Controller (USD Million)
  • Figure 13.3 Bioprocess Controller and Automation Market for Upstream / Downstream Controller Systems, Till 2035 (USD Million)
  • Figure 13.4 Bioprocess Controller and Automation Market for Bioprocess Control Software, Till 2035 (USD Million)
  • Figure 13.5 Bioprocess Controller and Automation Market, Till 2035: Distribution by Scale of Operation (USD Million)
  • Figure 13.6 Bioprocess Controller and Automation Market for Preclinical / Clinical Operations, Till 2035 (USD Million)
  • Figure 13.7 Bioprocess Controller and Automation Market for Commercial Operations, Till 2035 (USD Million)
  • Figure 13.8 Bioprocess Controller and Automation Market, Till 2035: Distribution by Mode of Operation (USD Million)
  • Figure 13.9 Bioprocess Controller and Automation Market for Batch / Fed-batch Manufacturing, Till 2035 (USD Million)
  • Figure 13.10 Bioprocess Controller and Automation Market for Perfusion Manufacturing, Till 2035 (USD Million)
  • Figure 13.11 Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Bioprocessing Systems (USD Million)
  • Figure 13.12 Bioprocess Controller and Automation Market for Single-use Systems, Till 2035 (USD Million)
  • Figure 13.13 Bioprocess Controller and Automation Market for Stainless Steel / Other Systems, Till 2035 (USD Million)
  • Figure 13.14 Bioprocess Controller and Automation Market, Till 2035: Distribution by Key Geographical Regions (USD Million)
  • Figure 13.15 Bioprocess Controller and Automation Market in North America, Till 2035 (USD Million)
  • Figure 13.16 d (USD Million)
  • Figure 13.17 Bioprocess Controller and Automation Market in Asia-Pacific and Rest of the World, Till 2035 (USD Million)
  • Figure 14.1 Concluding Remarks: Current Market Landscape of Upstream Controllers
  • Figure 14.2 Concluding Remarks: Current Market Landscape of Downstream Controller Systems
  • Figure 14.3 Concluding Remarks: Current Market Landscape of Bioprocess Control Software
  • Figure 14.4 Concluding Remarks: Patent Analysis
  • Figure 14.5 Concluding Remarks: Market Forecast and Opportunity Analysis